For the study published today in the Annals of Internal Medicine researchers analyzed insurance claims from nearly 3,600 women, ages 16 to 55, comparing pregnancies where GLP-1 medications were continued into the first trimester with pregnancies in which they were stopped
Body Composition Multiple peptide protocols support healthy body composition by reducing body fat, increasing lean muscle mass, and improving metabolic efficiency
Sorbitan Laurate
Changing frequency or dosage without supervision may lead to adverse effects or decreased efficacy
Presented for research literature review only Traina G et al
Studies examining body composition changes during GLP-1 therapy, including the STEP trials (semaglutide) and SURMOUNT-1 (tirzepatide), have demonstrated that approximately 2540% of total weight lost may come from lean body mass, including skeletal muscle, rather than exclusively from fat mass